2,0
9 ott 2011
Dipendente attuale
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Excellent pipeline that has a lot of potential. The oncology, RA, and biotech portfolios are really making inroads and will have a significant impact on patient treatment.
Svantaggi
Constant downsizing & restructuring leaves you always wondering when you'll be next to go. Pfizer still seems unprepared for Lipitor patent cliff.